Citation Impact

Citing Papers

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells
2012
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
Immunological aspects of cancer chemotherapy
2007
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
2020
Heat Shock Protein 90α in Nipple Discharge as a Potential Tumor Marker for Breast Cancer
2021
Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials
2018
Estrogen receptors and human disease
2006 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Emerging therapeutic opportunities for skeletal restoration
2011
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer
2004
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
2015
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document
2019
Osteoporosis: now and the future
2011 Standout
Cancer-associated cachexia
2018 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Genetic variants in pre-eclampsia: a meta-analysis
2013
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
2018
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
2014
Cyclin D as a therapeutic target in cancer
2011
Immunity, Inflammation, and Cancer
2010 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Environmental causes of cancer: endocrine disruptors as carcinogens
2010
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
2013
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers
2007
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
2000
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
2017
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
2006
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Pre-eclampsia
2015 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
The role of Dickkopf-1 in bone development, homeostasis, and disease
2008
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2009
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
2013 Standout
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2008
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
2016
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout

Works of Xiaohong Han being referenced

Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer
2008
Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients
2014
Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine
2013
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo
2007
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy
2009
The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy
2014
FASL –844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer
2005
Multistage prostate carcinogenesis: the role of hormones.
1991
Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer
2013
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways
2007
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma
2007
Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses
2014
Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta‐analysis
2018
A Severe Combined Immunodeficient–hu In vivo Mouse Model of Human Primary Mantle Cell Lymphoma
2008
Effect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials
2017
Rankless by CCL
2026